{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:24:08Z","timestamp":1780788248039,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1007\/bf01955263","type":"journal-article","created":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:52:49Z","timestamp":1122857569000},"page":"368-372","source":"Crossref","is-referenced-by-count":66,"title":["Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine"],"prefix":"10.1007","volume":"155","author":[{"given":"V.","family":"De Sanctis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pinamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sprocati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Atti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Gamberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01955263_CR1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bjo.68.12.873","volume":"68","author":"GB Arden","year":"1984","unstructured":"Arden GB, Wonke B, Kennedy C, Huehns ER (1984) Ocular changes in patients undergoing long-term desferrioxamine treatment. Br J Ophtalmol 68:873\u2013877","journal-title":"Br J Ophtalmol"},{"key":"BF01955263_CR2","first-page":"561","volume":"156","author":"PW Brill","year":"1991","unstructured":"Brill PW, Winchester P, Giardina PI, Cunnigham-Rundles S (1991) Desferrioxamine induced bone dysplasia in patients with thalassaemia major. A J R 156:561\u2013565","journal-title":"A J R"},{"key":"BF01955263_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.1984.tb06096.x","volume":"58","author":"A Cohen","year":"1984","unstructured":"Cohen A, Martin M, Schwartz E (1984) Depletion of excessive liver iron stores with desferrioxamine. Br J Haematol 58:369\u2013373","journal-title":"Br J Haematol"},{"key":"BF01955263_CR4","first-page":"181","volume":"II","author":"SC Davies","year":"1984","unstructured":"Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER (1984) Ocular toxicity of high dose intravenous desferrioxamine. Lancet II:181\u2013184","journal-title":"Lancet"},{"key":"BF01955263_CR5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2265.1994.tb02514.x","volume":"40","author":"V Sanctis De","year":"1994","unstructured":"De Sanctis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B (1994) Effect of different treatment regimes on linear growth and final height in \u03b2-thalassaemia major. Clin Endocrinol 40:791\u2013798","journal-title":"Clin Endocrinol"},{"key":"BF01955263_CR6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000207658","volume":"61","author":"S Virgilis De","year":"1979","unstructured":"De Virgilis S, Argiolu F, Sanna G, Cornacchia G, Cossu P, Cao A, Mallardi V, Puxcddu P (1979) Auditory involvement in thalassaemia major. Acta Haematol 61:209\u2013213","journal-title":"Acta Haematol"},{"key":"BF01955263_CR7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(88)80375-5","volume":"113","author":"S Virgilis De","year":"1988","unstructured":"De Virgilis S, Congia M, Frau F, Argiolu F, Diana G, Cucca F, Varsi A, Sanna G, Podda G, Fodde M, Pirastu GF, Cao A (1988) Desferrioxamine-induced growth retardation in patients with thalassemia major. J Pediatr 113:661\u2013669","journal-title":"J Pediatr"},{"key":"BF01955263_CR8","first-page":"41","volume":"44","author":"MG Elena","year":"1992","unstructured":"Elena MG, Fedele A, Gianino P, Giordanino S, Murru P, Tosi C, Vanelli S (1992) Velocit\u00e0 di crescita dei bambini talassemici sottoposti a diversi protocolli di terapia chelante. Min Pediatr 44:41\u201342","journal-title":"Min Pediatr"},{"key":"BF01955263_CR9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V76.3.435.435","volume":"76","author":"MT Fosburg","year":"1990","unstructured":"Fosburg MT, Nathan DG (1990) Treatment of Cooley's anemia. Blood 76: 435\u2013444","journal-title":"Blood"},{"key":"BF01955263_CR10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-6420(84)34267-1","volume":"91","author":"V Lankhanpal","year":"1986","unstructured":"Lankhanpal V, Schocket SS, Jiji R (1986) Desferrioxamine induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology 91:443\u2013451","journal-title":"Ophthalmology"},{"key":"BF01955263_CR11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00441542","volume":"148","author":"I Llados","year":"1989","unstructured":"Llados I, Vallory EA, Girot R, Lenoir G, Payet M, Houze P, Bourden R (1989) Studies of variations of subcutaneusly infused desferrioxamine and iron movements in thalassaemia children. Eur J Pediatr 148:503\u2013506","journal-title":"Eur J Pediatr"},{"key":"BF01955263_CR12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198604033141402","volume":"314","author":"NF Olivieri","year":"1986","unstructured":"Olivieri NF, Buncic JR, Chew E, Gallant T, Harrison RV, Keenan N, Looan W, Mitchell D, Ricci G, Skarf B, Taylor M, Freedman M (1986) Visual and auditory neurotoxicity in patients receiving subcutaneous desferrioxamine infusion. N Engl J Med 314:869\u2013873","journal-title":"N Engl J Med"},{"issue":"1","key":"BF01955263_CR13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00043426-199221000-00007","volume":"14","author":"NF Olivieri","year":"1992","unstructured":"Olivieri NF, Koren G, Harris J, Khattak S, Freedman M, Templeton DM, Bailey JD, Reilly BJ (1992) Growth failure and bony changes induced by desferoxamine. Am J Pediatr Hematol\/Oncol 14(1):48\u201356","journal-title":"Am J Pediatr Hematol\/Oncol"},{"key":"BF01955263_CR14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","volume":"331","author":"NF Olivieri","year":"1994","unstructured":"Olivieri NF, Nathan DG, Mac Millan JH, Wayne AS, Liu PP, Mc Gee A, Martin M, Koren G, Cohen AR (1994) Survival in medically treated patients with homozygous \u03b2-thalassaemia. N Eng J Med 331:574\u2013578","journal-title":"N Eng J Med"},{"key":"BF01955263_CR15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1989.tb07761.x","volume":"73","author":"JB Porter","year":"1989","unstructured":"Porter JB, Jaswon MS, Huhens ER, East CA, Jonathan WP (1989) Desferrioxamine ototoxicity: evaluation of risk factors in thalassemic patients and guidelines for safe dosage. Br J Haematol 73:403\u2013409","journal-title":"Br J Haematol"},{"key":"BF01955263_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0140-6736(91)90881-O","volume":"337","author":"P Rebulla","year":"1991","unstructured":"Rebulla P, Modell B (1991) Transfusion requirements and effects in patients with thalassaemia major. Lancet 337:277\u2013280","journal-title":"Lancet"},{"key":"BF01955263_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.1979.tb01167.x","volume":"42","author":"MR Summers","year":"1979","unstructured":"Summers MR, Jacobs A, Tudway D, Perera P, Ricketts C (1979) Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol 42:547\u2013555","journal-title":"Br J Haematol"},{"key":"BF01955263_CR18","first-page":"287","volume-title":"Textbook of paediatrics. Second edition","author":"JM Tanner","year":"1978","unstructured":"Tanner JM (1978) Physical growth and development. In: Forfar JD, Arneil GC (eds) Textbook of paediatrics. Second edition. Livingston, Edinburgh, pp 287\u2013290"},{"key":"BF01955263_CR19","volume-title":"The thalassaemia syndromes","author":"DJ Weatherall","year":"1981","unstructured":"Weatherall DJ, Clegg JG (1981) The thalassaemia syndromes. Third edition. Blackwell Scientific Publication, Oxford","edition":"Third edition"},{"key":"BF01955263_CR20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM198506203122503","volume":"312","author":"L Wolfe","year":"1985","unstructured":"Wolfe L, Olivieri N, Sallan D, Olan S, Rose W, Propper R, Freedman M, Nathan D (1985) Prevention of cardiac disease by subcutaneous desferrioxamine in patients with thalassemia major. N Engl J Med 312:1600\u20131603","journal-title":"N Engl J Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01955263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01955263\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01955263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T14:08:13Z","timestamp":1586354893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01955263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["BF01955263"],"URL":"https:\/\/doi.org\/10.1007\/bf01955263","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}